Article
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18 labelled tetrazine
2025-06-03
Abstract excerpt
<title>Abstract</title> <p>Antibody-based positron emission tomography (PET) imaging holds promise for visualising and quantifying disease-related proteins in the brain, yet clinical application has been limited by the poor blood-brain barrier (BBB) penetration of antibodies and the need for long-lived radionuclides. Pretargeted imaging offers a solution by separating the delivery of the antibody from the radiola...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d04ab47-a9c3-5dad-8589-6c1988bb186a
- DOI
- 10.21203/rs.3.rs-6784648/v1
